17.60

8.57% -1.65

After Hours: 17.60

Pulse Biosciences Inc (PLSE)

Overview News Price History Option Chain Financials Discussions Forecast

Pulse Biosciences Inc stock is traded at $17.60, with a volume of 236.23K. It is down -8.57% in the last 24 hours and up +19.16% over the past month. Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Previous Close:

$19.25

Open:

$19.28

24h Volume:

236.23K

Relative Volume:

1.30

Market Cap:

$1.18B

Revenue:

$-9,000

Net Income/Loss:

$-68.03M

P/E Ratio:

-16.76

EPS:

-1.05

Net Cash Flow:

$-44.76M

1W Performance:

-8.76%

1M Performance:

+19.16%

6M Performance:

+13.11%

1Y Performance:

+12.82%

1-Day Range:

$17.45

$19.35

1-Week Range:

$17.45

$20.20

52-Week Range:

$13.77

$25.00

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name

Pulse Biosciences Inc

Sector

Healthcare (1141)

Industry

Medical Instruments & Supplies (58)

Phone

510-906-4600

Address

3957 POINT EDEN WAY, HAYWARD, CA

Employee

Twitter

@PulseBioNPS

Next Earnings Date

2024-10-30

Latest SEC Filings

PLSE's Discussions on Twitter

Compare PLSE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PLSE Pulse Biosciences Inc	17.60	1.30B	-9,000	-68.03M	-44.76M	-1.05
ISRG Intuitive Surgical Inc	429.59	159.08B	9.15B	2.63B	1.99B	7.1661
BDX Becton Dickinson Co	186.56	54.20B	21.39B	1.61B	2.55B	5.5609
RMD Resmed Inc	272.00	40.55B	5.15B	1.40B	1.65B	9.5082
ALC Alcon Inc	72.05	36.85B	10.03B	1.07B	1.39B	2.1549
WST West Pharmaceutical Services Inc	261.77	18.95B	2.96B	487.70M	344.00M	6.6758

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-07-25	Initiated	Oppenheimer	Outperform
Jul-27-21	Initiated	Stephens	Overweight
Mar-11-21	Initiated	Maxim Group	Buy
Jan-26-21	Reiterated	H.C. Wainwright	Buy
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-25-19	Initiated	H.C. Wainwright	Buy

View All

Pulse Biosciences Inc Stock (PLSE) Latest News

Oct 10, 2025

Pulse Biosciences Reveals Positive First-in-Human PFA Data - Medical Product Outsourcing

Oct 10, 2025

Is Pulse Biosciences Inc. stock bottoming outJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com

Oct 10, 2025

Pulse Biosciences announces presentation of late-breaking data from the nPulse cardiac surgical system - MarketScreener

Oct 10, 2025

Pulse Biosciences Announces Results from nPulse Cardiac Surgical System Study - TradingView

Oct 10, 2025

Pulse Biosciences, Inc. Announces Presentation of Late-Breaking Data from the nPulse Cardiac Surgical System First-In-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - MarketScreener

Oct 10, 2025

Pulse Biosciences reports positive results for cardiac ablation system - Investing.com India

Oct 10, 2025

Pulse Biosciences reports positive results for cardiac ablation system By Investing.com - Investing.com South Africa

Oct 10, 2025

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Yahoo Finance

Oct 10, 2025

Is now a turning point for Pulse Biosciences Inc.July 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com

Oct 10, 2025

Pulse Biosciences (NASDAQ:PLSE) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 10, 2025

Heatmap analysis for Pulse Biosciences Inc. and competitorsJuly 2025 Trends & Long-Term Capital Growth Strategies - newser.com

Oct 10, 2025

Oct 09, 2025

Will Pulse Biosciences Inc. continue its uptrendMarket Activity Summary & Real-Time Sentiment Analysis - newser.com

Oct 09, 2025

Oct 08, 2025

What analysts say about Pulse Biosciences Inc 6L8 stockTrendline Breakouts & Outstanding Investment Portfolio - earlytimes.in

Oct 08, 2025

Oct 07, 2025

Insider Selling: Pulse Biosciences (NASDAQ:PLSE) Insider Sells 4,600 Shares of Stock - MarketBeat

Oct 07, 2025

Pulse Biosciences introduces nPulse Vybrance for nsPFA technology - Traders Union

Oct 07, 2025

Pulse Biosciences Announces Clinical Data Highlighting its nPulse Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Investing News Network

Oct 07, 2025

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - MarketScreener

Oct 07, 2025

Oct 03, 2025

Pulse Biosciences (NASDAQ:PLSE) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat

Oct 03, 2025

Pulse Biosciences (PLSE) Is Up 11.1% After FDA Clears Cardiac Ablation StudyWhat's Changed - Sahm

Oct 03, 2025

Pulse Biosciences (PLSE): Evaluating Its Valuation After Recent Investor Interest - Sahm

Oct 03, 2025

Using Ichimoku Cloud for Pulse Biosciences Inc. technicals2025 Dividend Review & Technical Buy Zone Confirmation - newser.com

Oct 03, 2025

What does recent volatility data suggest for Pulse Biosciences Inc.Buy Signal & Momentum Based Trading Signals - newser.com

Oct 03, 2025

Oct 02, 2025

Pulse Biosciences Expands Equity Incentive Plan - MSN

Oct 02, 2025

Oct 01, 2025